David D. Davidar - 18 Jan 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Reporting relationship: Director
Issuer ticker: GMED
Reported as of: 18 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jan 2024, 16:52:33 UTC
Prior SEC filing: 27 Feb 2023
Next SEC filing: 30 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Kelly G. Huller, Attorney-in-Fact

Key filing fact

David D. Davidar filed Form 4 for GLOBUS MEDICAL INC (GMED) on 25 Jan 2024.

Key facts

This page summarizes David D. Davidar's Form 4 filing for GLOBUS MEDICAL INC (GMED).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Jan 2024, 16:52.

Change

Previous filing in this sequence was filed on 27 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GMED transaction

Class A Common Stock

Gift

Transaction value: $0
Shares: -8,000
Change %: -1.3%
Price: $0.000000
Shares after: 586,275
Date: 18 Jan 2024
Ownership: Direct

GMED holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 205,967
Date: 18 Jan 2024
Ownership: By Davidar Family Irrevocable Trust U/A 8/6/09
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.